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Summary
Electroencephalographic density spectral array monitoring has been developed to facilitate the interpretation
of unprocessed electroencephalogram signals. The primary aim of this prospective observational study,
performed in a tertiary children’s hospital, was to identify the clinical applicability and validity of density spectral
array monitoring in infants and children during sevoﬂurane anaesthesia. We included 104 children, aged
< 6 years, undergoing elective surgery during sevoﬂurane anaesthesia. We investigated the correlation
between non-steady state end-tidal sevoﬂurane and the expression of the four electroencephalogram
frequency bands b, a, h and d, representing density spectral array. Patients were divided into three age groups
(< 6 months, 6–12 months, > 12 months). There was a signiﬁcant correlation between end-tidal sevoﬂurane
and density spectral array in the age groups 6–12 months (p < 0.05) and 1–6 years (p < 0.0001). In infants
< 6 months of age, the relative percentages of density spectral array did not correlate with end-tidal
sevoﬂurane. The main ﬁnding was that different end-tidal concentrations of sevoﬂurane produce age-
dependent changes in the density spectral array power spectrum. In infants younger than 6 months-old, a and b
coherence are absent, whereas h and d oscillations have already emerged. In cases where anaesthesia was too
deep, this presented as burst suppression on the electroencephalogram, h disappeared, leaving the
electroencephalographic activity in the d range. Future research should address this issue, aiming to clarify
whether the emergence of h oscillations in infants helps to prevent sevoﬂurane overdosing.
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Introduction
Electroencephalographic density spectral array (DSA)
monitoring has been proposed to facilitate the
interpretation of unprocessed electroencephalogram (EEG)
signals in patients undergoing general anaesthesia [1].
Encephalographic DSA is a three-dimensional method to
display EEG signals consisting of the EEG frequency (y-axis),
the power of the EEG signal (originally the z-axis, but colour-
coded to be integrated into a two-dimensional plot) and the
development of the EEG power spectrum over time (x-axis).
The power spectrum is encoded in different colours; blue
implies minimal power and red implies high or maximal
power [1, 2]. Compared with processed EEG monitoring,
DSA provides real-time EEG information [3]. One of the
major advantages of real-time DSA EEG monitoring is the
lack of any delay in detecting even subtle changes in the
© 2018 The Authors. Anaesthesia published by JohnWiley & Sons Ltd on behalf of Association of Anaesthetists 1
This is an open access article under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs License, which permits use and
distribution in anymedium, provided the original work is properly cited, the use is non-commercial and nomodiﬁcations or adaptations aremade.
Anaesthesia 2018 doi:10.1111/anae.14458
depth of hypnosis. However, DSA has not yet been widely
implemented in the daily practice of paediatric anaesthesia.
We decided to investigate the additional value of DSA in
children undergoing sevoﬂurane anaesthesia. The primary
outcome parameter of this prospective observational study
in children < 6 years of age was to determine the
correlation between DSA and various non-steady-state
sevoﬂurane concentrations.
Methods
Following local research ethics committee approval,
informed consent was obtained from the parents of all the
children. We included children from birth to 6 years of
age, scheduled to undergo elective surgery in the
Erasmus MC-Sophia Children’s Hospital. Anaesthesia
maintained with sevoﬂurane as the sole anaesthetic agent
was the main inclusion criterion. Exclusion criteria were
non-elective procedures, neurosurgical procedures and
the use of premedication. Standard monitoring, consisting
of ECG, NIBP, capnography, pulse oximetry and end-tidal
sevoﬂurane (ETsevo) was applied.
Electroencephalographic monitoring of the depth of
anaesthesia was performed using the Narcotrend EEG
monitor (MTMonitortechnik, BadBramstedt, Germany). The
Narcotrend calculates an index of hypnotic depth, ranging
from 100 (fully awake) to 0 (very deep hypnosis), called the
Narcotrend index. As well as the processed Narcotrend
index, the Narcotrend monitor records the EEG power
spectrum, relative power in b (% b: 13–25 Hz), a (% a: 9–
12 Hz), h (% h: 5–8 Hz) and d (% d: 1–4 Hz), and DSA.
Patients were attached to the Narcotrend monitor,
according to the manufacturer’s recommendations, using
three electrodes positioned on the forehead.
Induction of anaesthesia was performed using a
facemask with sevoﬂurane, or with intravenous (i.v.)
propofol. The end-tidal sevoﬂurane concentration was
chosen by the attending anaesthetist, aiming to maintain an
adequate depth of anaesthesia based on individual clinical
judgement. The attending anaesthetist did not have access
to the screen of the depth of hypnosis monitor. Raw EEG
data were continuously recorded in each patient and
exported as Excel ﬁles for subsequent analysis using the
EEG ViewerTM software package (Version 1.6, MT
MonitorTechnik GmbH & Co. KG, Bad Bramstedt,
Germany).
Intra-operative use of propofol, opioids, other
analgesics and locoregional techniques were recorded. If
induction of anaesthesia was performed with i.v. propofol,
then DSA monitoring was commenced 15 min after
induction. If a bolus of propofol was given during
maintenance of anaesthesia, DSA measurements were
postponed for 15 min after the bolus in order to exclude the
effect of propofol on theDSA relative power percentages.
Based on previously performed studies [4, 5], patients
were divided into three different age groups (< 6 months;
6–12 months; and 1–6 years) for analysis.
In order to investigate variations in total power between
different age groups, we performed a one-way ANOVAwith
a Games–Howell post-hoc test. Spearman correlation was
performed to analyse the correlation between ETsevo and
the relative EEG power percentages. The relationship
betweenDSA relative power and ETsevo was displayed using
a heatmap, a graphical tool representing grouped data.
Continuous variables were tested for normality using the
D’Agostino–Pearson omnibus test and the Shapiro–Wilk
normality test. Statistical analysis was performed using SPSS
for Mac (version 22.0 SPSS Inc., Chicago, IL, USA) and
GraphPad Prism 7 for Mac (version 7.0, GraphPad Software
Inc., San Diego, CA, USA). A p value of < 0.05 was
considered statistically signiﬁcant.
Results
We recorded data in 108 children. Data from four patients
had to be excluded; one patient was not included due to the
use of premedication (group 3) and three due to technical
issues with data collection (two who were < 6 months old
and one who was between 1–6 years of age). This resulted
in 104 datasets being available for analysis. Baseline
characteristics of patients included in the study are shown in
Table 1.
There was a signiﬁcant difference in total power
between the three different age groups (Table 2). There
was a signiﬁcant correlation between ETsevo and relative
EEG power in b, a, h and d in children aged 6–12 months
Table 1 Baseline characteristics of patients included in the study. Values aremedian (IQR [range]) or number (proportion).
0–6 monthsold 6–12 months old 1–6 years old
n = 23 n = 30 n = 51
Age;months 3 (2–4 [0–5]) 9 (7–10 [6–11]) 27 (14–46 [12–70])
Weight; kg 4.8 (3.8–6.0 [2.0–8.3]) 8.0 (7.4–9.0 [6.2–10.0]) 12.0 (10.0–15.0 [7.0–30.0])
Sex; female 5 (22%) 2 (7%) 19 (37%)
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and 1–6 years. (Table 3). From 6 months of age, the ETsevo
concentration had a signiﬁcant negative correlation with the
relative percentage of b and a, and a signiﬁcantly positive
correlation with h and d. In infants < 6 months of age, no
signiﬁcant correlationwas found.
Increasing ETsevo caused augmentation in frontal h and
d activity and a decrease in b and a oscillations in children
> 6 months. In infants < 6 months, the EEG power
spectrum consisted mainly of d oscillations and minimal h
oscillations. The b and a oscillations were absent in this age
group. This effect of ETsevo on DSA is illustrated using
heatmaps (Fig. 1).
Figure 2 shows some typical examples of the
relationship between the ETsevo concentration, the
Narcotrend index and the DSA colour spectrum in each
age group. Figures 2b and 2c show an example of the
positive correlation of h and d with ETsevo in a 9-month-old
infant and a 38-month-old child, respectively. The negative
correlation of b and a with ETsevo is best seen in Fig. 2b.
Figure 2a of a 3-month-old infant shows no b or a
oscillations and just a little h expression at between 0 and
30 min.
The Narcotrend index calculation failed in 13% of
patients age < 6 months compared with 3% age 6–
12 months. In 39% of patients age < 6 months Narcotrend
index monitoring partially failed, compared with 7% in age
6–12 months and 6% age 1–6 years.
In three patients, propofol was administered during
maintenance of anaesthesia because the surgeon reported
patient movement. In two of these patients (age
< 6 months) no difference in DSA colour spectrum was
Table 2 Multiple comparisons betweendifferent age groups usingGames–Howell non-parametric post-hoc test.
SE pvalue Meandifference (95%CI)
0–6 months 6–12 months 84.7 0.001 322.7 (528.0 to117.4)
1–6 years 244.7 <0.001 1806.3 (2395.0 to1217.7)
6–12 months 1–6 years 241.5 <0.001 1483.6 (2065.3 to901.9)
SE, standard error.
Table 3 Spearman correlation analysis for the three groups included in the study. Values are r (95%CI).
ETsevo ETsevo ETsevo
0–6 months 6–12 months 1–6 years
Rel. b% 0.17 (0.18 to 0.47) 0.82 (0.91 to0.65)** 0.77 (0.88 to0.60)**
Rel. a% 0.25 (0.09 to 0.54) 0.54 (0.75 to0.22)* 0.68 (0.83 to0.45)**
Rel. h% 0.33 (0.00 to 0.60) 0.81 (0.65 to 0.91)** 0.80 (0.64–0.90)**
Rel. d% 0.24 (0.53 to 0.10) 0.74 (0.52 to 0.87)** 0.70 (0.47–0.83)**
*p < 0.050.
**p < 0.001.
Figure 1 The effect of ETsevo onDSA. (a) represents infants
aged 0–6 months, (b) represents infants aged 6–12 months
and (c) represents children aged 1–6 years.
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Figure 2 Examples of the relationship between the ETsevo concentration, theNarcotrend index and the density spectral array
(DSA) colour spectrum in each age group; (a) represents a 3-month-old infant, a 9-month-old infant is represented in (b), and (c)
represents a 38-month-old child. The red line indicatesNarcotrend index and the blue line ETsevo concentration.
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identiﬁed before the administration of propofol. In the third
patient (age 1–6 years), due to technical issues, no EEG
data could be recorded at the moment of propofol
administration.
Discussion
The main ﬁnding of this clinical observational study is that
different end-tidal concentrations of sevoﬂurane produce
changes in DSA power spectrum and appear to be age
dependent.
In children > 6 months, heatmaps show a profound
dose-dependent sevoﬂurane effect on EEG power. This
effect is less obvious in infants < 6 months. With increasing
age, a signiﬁcant increase in EEG total power was identiﬁed.
This ﬁnding is in accordance with a previously performed
study by Akeju et al. [4]. The a coherence is deﬁned as a
prominent EEG feature associated with sevoﬂurane-
induced general anaesthesia [1, 6]. In our study, in patients
< 6 months, d and h coherence is present and b and a
coherence is absent. Akeju et al. showed a coherence was
absent in a very small group of four patients aged < 1 year
[4]. Cornelissen et al., who used full-scale EEG monitoring
during sevoﬂurane general anaesthesia, reported the
emergence of a and h oscillations in children at
approximately 4 months of age [7].
Processed EEG devices such as the bispectral index
monitor and the Narcotrend index monitor are more often
used in paediatric anaesthesia practice than DSA. The
studies designed to validate these monitors in children
were mostly performed in those aged > 5 months and
were mainly focused on the ability of an index value to
distinguish between the awake and the unconsciousness
state [8, 9].
Dennhardt et al. [10] recently investigated the effect
of age on Narcotrend index monitoring during
sevoﬂurane anaesthesia. They reported limited feasibility
of the Narcotrend index monitor in infants < 4 months of
age due to the lower likelihood (29.6%) of showing a
Narcotrend index. In our study, the feasibility of the
Narcotrend index to generate a value was also reduced in
age < 6 months. McKeever et al. [11], demonstrated the
relationship between age-adjusted minimum alveolar
concentration (MAC) multiples and amplitude-integrated
electroencephalography (aEEG) in young children. They
found that aEEG in children < 2 years of age did not
correlate with MAC. In their study, in infants aged 1–
6 months, spectral edge frequency 90 (SEF90) did not
correlate with MAC and the bispectral index (BIS)
performed poorly. These ﬁndings are in accordance with
the conclusion made by Davidson [8] that depth of
anaesthesia monitors may not function in infants or young
children.
With knowledge that the processed EEG does not
appear to function, and that there is no signiﬁcant
correlation between relative power in h in infants
< 6 months old, the question remains as to whether it
makes sense at all to use EEG monitoring during
anaesthesia in this age group. However, we believe there is
a place for EEGmonitoring in this vulnerable patient group.
Although ETsevo and h oscillations are not signiﬁcantly
correlated in infants < 6 months old, the oscillations are at
least present. This does not appear to be the casewith b and
a oscillations. It is widely accepted that too deep a level of
anaesthesia is almost always associated with burst
suppression and disappearance of h oscillations, leaving
EEG activity in the d range [1]. Therefore, from a
neurophysiological perspective, the presence or absence
of h oscillations in young infants under sevoﬂurane
anaesthesia may be an indicator of anaesthetic depth.
Future research should address this issue, aiming to clarify
whether the emergence of h oscillations in infants
anaesthetised with sevoﬂurane helps to prevent these
patients from relative sevoﬂurane overdose, making it a
meaningful EEG signature in recording the depth of
anaesthesia in infants.
A limitation of this study is that we only focused on the
effect of ETsevo on DSA and did not use a clinical scale or
scoring system to monitor anaesthetic depth. As a
consequence, we cannot use this study as validation to
investigate the ability of DSA to differentiate between
different levels of consciousness in young children.
In conclusion, this observational study provides
additional evidence of the applicability of DSA as ameasure
of anaesthetic depth in young children undergoing
sevoﬂurane anaesthesia. We believe there is an additional
value to DSA in hypnotic depthmonitoring in children aged
6 months to 6 years due to a signiﬁcant correlation
between DSA and ETsevo. In infants < 6 months, DSA may
be a useful tool in preventing sevoﬂurane overdosing due
to the emergence of h expression. Further research using
DSA should speciﬁcally address the issue of sevoﬂurane
overdosing in infants aged 0–6 months.
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